BioSpace News Archive

Business

CytoDyn Announces Leadership Changes to Align with Expanded Focus of PRO 140 to Cancer and Immunological Disorders

CytoDyn Inc. announces leadership changes that align with the strategic expansion of its focus with PRO 140 to cancer and immunological disorders, separately announced today.

July 12, 2018
·
9 min read
Business

ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2018 Operating Results

ImmunoGen, Inc., announced that Company will host a conference call at 8:00 a.m. ET on Friday, July 27, 2018 to discuss its second quarter operating results.

July 12, 2018
·
1 min read
Policy

Gilead Receives Approval in Canada for BIKTARVY™ (bictegravir, emtricitabine, tenofovir alafenamide) for the Treatment of HIV-1 Infection

In clinical trials, BIKTARVY demonstrated high efficacy, and a high barrier to resistance

July 12, 2018
·
7 min read
Pharm Country

Novartis launches the Galaxies of Hope app, a digital experience for the Neuroendocrine Tumor (NET) cancer community

Galaxies of Hope offers a unique digital experience that engages users through the art of visual storytelling to connect with others to understand NET cancer

July 12, 2018
·
3 min read
Business

MedReleaf to Sponsor Cancer Trial in Collaboration with the Ontario Clinical Oncology Group

In affiliation with Hamilton Health Sciences and the Department of Oncology at McMaster University

July 12, 2018
·
2 min read
Business

DarioHealth CEO Erez Raphael’s Interview Published in Research 2 Guidance

DarioHealth Corp. announced that Research2Guidance, an analyst and strategic consulting company for the digital health industry, published an interview of DarioHealth CEO, Erez Raphael titled “Using real-time data to feed predictive care models for diabetes management.”

July 12, 2018
·
4 min read
Drug Development

Aldeyra Therapeutics Announces Last Patient Dosed in Dry Eye Disease Phase 2b Clinical Trial

Aldeyra Therapeutics, Inc. announced that the last patient has completed dosing in Aldeyra’s randomized, double-masked, vehicle-controlled, multi-center, parallel-group Phase 2b clinical trial of topical ocular reproxalap in dry eye disease.

July 12, 2018
·
6 min read
Business

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

SkinCure Provides Turnkey Solution for Sensus’ SRT-100 Vision™, Aimed at Dermatology Community

July 12, 2018
·
8 min read
Business

GeneNews’ Innovative Diagnostic Laboratory Appoints David Byram Chief Commercial Officer

GeneNews Limited announced the appointment of David Byram as the Chief Commercial Officer for its U.S. Lab, Innovative Diagnostic Laboratory, LLP

July 12, 2018
·
3 min read
Business

Incyte to Report Second Quarter 2018 Financial Results

Incyte Corporation announced that it has scheduled its second quarter 2018 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 31, 2018.

July 12, 2018
·
1 min read